Flanagan Michael W.'s Insider Trades & SAST Disclosures
Flanagan Michael W.'s most recent trade in Avidity Biosciences Inc was a trade of 11,780 Common Stock done at an average price of $31.1 . Disclosure was reported to the exchange on March 20, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Flanagan Michael W..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 31.06 per share. | 20 Mar 2025 | 11,780 | 80,195 | - | 31.1 | 365,868 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2025 | 20,000 | 116,500 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 30.13 per share. | 11 Mar 2025 | 20,000 | 91,975 | - | 30.1 | 602,614 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.22 per share. | 11 Mar 2025 | 20,000 | 111,975 | - | 14.2 | 284,400 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 28.60 per share. | 21 Jan 2025 | 3,860 | 93,787 | - | 28.6 | 110,383 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 28.59 per share. | 21 Jan 2025 | 1,812 | 91,975 | - | 28.6 | 51,809 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 25,000 | 97,647 | - | 0 | Common Stock | |
| Avidity Biosciences Inc | Flanagan Michael W. | CSTO | Sale of securities on an exchange or to another person at price $ 32.66 per share. | 18 Dec 2024 | 12,742 | 72,647 | - | 32.7 | 416,154 | Common Stock |
| Avidity Biosciences Inc | Flanagan Michael W. | CSTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 24,000 | 86,000 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | W. Flanagan Michael | CSTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.47 per share. | 11 Dec 2024 | 24,000 | 109,389 | - | 22.5 | 539,280 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Sale of securities on an exchange or to another person at price $ 35.77 per share. | 11 Dec 2024 | 24,000 | 85,389 | - | 35.8 | 858,401 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.75 per share. | 01 Oct 2024 | 62,500 | 147,889 | - | 26.8 | 1,671,875 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2024 | 62,500 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Sale of securities on an exchange or to another person at price $ 47.62 per share. | 01 Oct 2024 | 62,500 | 85,389 | - | 47.6 | 2,976,113 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2024 | 25,000 | 97,718 | - | 0 | Common Stock | |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2024 | 25,000 | 85,871 | - | 0 | Common Stock | |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Sale of securities on an exchange or to another person at price $ 44.00 per share. | 19 Sep 2024 | 13,153 | 72,718 | - | 44.0 | 578,737 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Sale of securities on an exchange or to another person at price $ 43.89 per share. | 19 Sep 2024 | 11,847 | 85,389 | - | 43.9 | 519,996 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.75 per share. | 11 Sep 2024 | 62,500 | 138,265 | - | 26.8 | 1,671,875 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2024 | 62,500 | 87,500 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Sale of securities on an exchange or to another person at price $ 40.40 per share. | 11 Sep 2024 | 62,500 | 75,765 | - | 40.4 | 2,525,013 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2024 | 34,000 | 110,000 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Sale of securities on an exchange or to another person at price $ 40.40 per share. | 11 Sep 2024 | 34,000 | 75,765 | - | 40.4 | 1,373,556 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.47 per share. | 11 Sep 2024 | 34,000 | 109,765 | - | 22.5 | 763,980 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Sale of securities on an exchange or to another person at price $ 40.40 per share. | 11 Sep 2024 | 14,894 | 60,871 | - | 40.4 | 601,676 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 25,000 | 75,765 | - | 0 | Common Stock | |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 25,000 | 60,871 | - | 0 | Common Stock | |
| Avidity Biosciences Inc | W. Michael Flanagan | CSTO | Sale of securities on an exchange or to another person at price $ 39.13 per share. | 17 Jun 2024 | 10,106 | 50,765 | - | 39.1 | 395,445 | Common Stock |
| Avidity Biosciences Inc | Michael Flanagan W. | CSTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2024 | 88,000 | 88,000 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Flanagan Michael W. | CSTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2024 | 20,000 | 20,290 | - | 0 | Common Stock | |
| Avidity Biosciences Inc | W. Flanagan Michael | CSTO | Sale of securities on an exchange or to another person at price $ 10.13 per share. | 20 Jan 2024 | 4,129 | 35,871 | - | 10.1 | 41,827 | Common Stock |
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 144,000 | 144,000 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 40,000 | 40,290 | - | 0 | Common Stock | |
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2022 | 136,500 | 136,500 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | W. Michael Flanagan | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2021 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges